LIVE
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

COHANCE

NSEBSE
Cohance Lifesciences Limited
Healthcare· Pharmaceuticals & Biotechnology· INE03QK01018· Scrip: 543064
ENहिन्दीગુજરાતીमराठी
૪૮૭.૯૦
3.05 (+0.63%)
8/5/2026, 3:29:51 pm
NSE
૪૮૭.૯૦
૩.૦૫
+૦.૬૩%
BSE
૪૮૮.૩૦
૩.૪૦
+૦.૦૦%
2794876969051,11405-1907-1109-0811-0412-3102-2605-0505-08
૨૩૮ ટ્રેડિંગ દિવસ · 1Y સમયગાળો
આજ
ખૂલ્લ૪૮૪.૮૫
ઊંચ૫૦૨.૩૫
નીચ૪૮૧.૦૦
અગાઉ બંધ૪૮૪.૮૫
વૉલ્યુમ૨૩.૨૭L
મૂલ્ય₹૧૧૪.૫Cr
L: 481.00H: 502.35
52 સપ્તાહ
નીચ૨૬૬.૭૦
ઊંચ૧,૧૫૮.૩૦
૨૫% 52 સપ્તાહ રેન્જમાં
માહિતી
અંકિત મૂલ્ય₹૧
સૂચિબદ્ધ2020-03-09
ISININE03QK01018
SeriesA
BSE સ્ક્રિપ543064

મુખ્ય સૂચકો

1D
+0.63%
1W
+0.96%
1M
+62.34%
3M
+27.89%
6M
-42.63%
મૂલ્યાંકન
P/E (TTM)૪૪.૪૪
P/E (Qtr Ann.)૩૭.૪૨
P/Sales૧૧.૧૫
વૃદ્ધિ (ત્રિ.)
આવક+19.18%
PAT+1.60%
EPS+0.93%
નફાકારકતા
TTM EBITDA M.૪૧.૧%
TTM આવક
₹1048 Cr
TTM EBITDA
₹431 Cr
TTM PAT
₹279 Cr
TTM EPS
₹૧૦.૯૮

ત્રિમાસિક નાણાકીય

આવક
EBITDA
PAT
EPS
0 Cr92 Cr185 Cr277 Cr369 Cr23-0323-0623-0923-1224-0324-0624-0924-124.94.73.11.82.12.43.23.3
ત્રિમાસઆવકExpensesEBITDAPBTPATEPS
2024-12-31307 Cr213 Cr130 Cr110 Cr83 Cr3.26
2024-09-30258 Cr172 Cr116 Cr100 Cr82 Cr3.23
2024-06-30231 Cr166 Cr96 Cr83 Cr61 Cr2.39
2024-03-31253 Cr199 Cr88 Cr71 Cr53 Cr2.10
2023-12-31220 Cr169 Cr78 Cr65 Cr47 Cr1.84
2023-09-30231 Cr145 Cr117 Cr105 Cr80 Cr3.13
2023-06-30348 Cr194 Cr176 Cr164 Cr121 Cr4.74
2023-03-31369 Cr215 Cr178 Cr166 Cr124 Cr4.87

શેરહોલ્ડિંગ પેટર્ન

વર્તમાન2026-03-31
57.5%પ્રમોટર
પ્રમોટર57.5%
FII5.6%
DII21.8%
સાર્વજનિક42.5%
સરકાર0.0%
પ્રમોટર હોલ્ડિંગ ટ્રેન્ડ
50.1%24-0950.1%24-1250.1%25-0366.4%25-0557.5%25-0957.5%25-1257.5%26-03

કોર્પોરેટ ક્રિયાઓ

એક્સ-તારીખપ્રકારહેતુ
2024-08-06OtherAnnual General Meeting
2023-12-12OtherAnnual General Meeting
2022-09-09DividendInterim Dividend - Re 1 Per Share/Special Dividend- Rs 5 Per Share
2022-08-11OtherAnnual General Meeting
2022-05-13DividendInterim Dividend - Re 1 Per Share/Special Dividend - Re 1 Per Share
2022-02-15DividendInterim Dividend - Re 1 Per Share/ Special Dividend - Rs 2 Per Share
2021-08-13Dividend Annual General Meeting/Dividend - Re 1 Per Share
2021-02-17Dividend Interim Dividend - Re 1 Per Share
2020-09-25Bonus Bonus 1:1

કમાણી ટ્રાન્સક્રિપ્ટ

Cohance Lifesciences Limited has informed the Exchange about Investor Presentation
12 Nov 2025NSE47K chars
Read →
Cohance Lifesciences Limited has informed the Exchange about Schedule of the results conference call
5 Nov 2025NSE3K chars
Read →
Cohance Lifesciences Limited has informed the Exchange about Investor Presentation
13 Aug 2025NSE36K chars
Read →
Cohance Lifesciences Limited has informed the Exchange about Investor Presentation
28 May 2025NSE45K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
12 Feb 2025NSE56K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
29 Feb 2024NSE40K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
24 Nov 2023NSE28K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
9 Nov 2023NSE22K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional I...
15 Nov 2022NSE39K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional I...
16 Aug 2022NSE36K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
8 Aug 2022NSE8K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional I...
8 Jun 2022NSE77K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional I...
13 May 2022NSE41K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Revised Investor Presentation
9 May 2022NSE8K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
9 May 2022NSE8K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
8 Feb 2022NSE9K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
6 Nov 2021NSE8K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
16 Aug 2021NSE7K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
8 Jun 2021NSE7K chars
Read →
Suven Pharmaceuticals Limited has informed the Exchange about Investor Presentation
11 Feb 2021NSE8K chars
Read →

ભાવ ઇતિહાસ

તારીખખૂલ્લઊંચનીચબંધવૉલ્યુમ
2026-05-08૪૮૪.૮૫૫૦૨.૩૫૪૮૧.૦૦૪૮૮.૨૦૨૩.૩૮L
2026-05-07૪૮૬.૫૦૪૯૪.૨૦૪૭૮.૫૫૪૮૪.૮૫૧૯.૧૭L
2026-05-06૪૫૯.૦૦૪૯૯.૦૦૪૫૯.૦૦૪૮૧.૨૫૧.૪૨Cr
2026-05-05૪૬૭.૮૫૪૬૭.૮૫૪૫૦.૮૦૪૫૪.૧૫૧૪.૩૭L
2026-05-04૪૮૭.૦૦૪૯૦.૦૦૪૬૫.૫૦૪૭૦.૭૫૧૮.૭૯L
2026-04-30૪૬૯.૭૦૪૯૮.૮૦૪૪૨.૬૦૪૮૩.૨૫૧.૨૫Cr
2026-04-29૪૯૪.૮૫૫૦૬.૦૦૪૬૦.૧૦૪૬૭.૫૫૬૮.૭૩L
2026-04-28૪૪૪.૪૫૫૧૪.૯૦૪૪૪.૦૦૪૯૩.૩૦૪.૦૯Cr
2026-04-27૩૮૦.૩૫૪૩૨.૧૦૩૭૯.૦૦૪૩૨.૧૦૧.૩૯Cr
2026-04-24૩૬૫.૬૫૩૬૯.૮૦૩૫૫.૦૫૩૬૦.૧૦૯.૦૧L
2026-04-23૩૬૪.૪૫૩૭૪.૮૫૩૬૦.૫૦૩૬૩.૯૦૧૮.૩૫L
2026-04-22૩૬૪.૦૦૩૭૨.૯૦૩૬૦.૩૫૩૬૨.૯૦૧૪.૫૫L
2026-04-21૩૬૯.૨૦૩૭૦.૮૦૩૫૯.૨૫૩૬૧.૨૦૧૯.૦૭L
2026-04-20૩૮૮.૦૦૩૮૮.૦૦૩૬૭.૦૦૩૬૯.૨૦૩૨.૦૮L
2026-04-17૩૬૨.૯૫૪૦૬.૫૦૩૫૯.૫૦૩૯૦.૫૫૧.૩૫Cr
2026-04-16૩૬૦.૦૦૩૬૫.૬૫૩૫૪.૪૫૩૬૨.૯૫૧૩.૮૭L
2026-04-15૩૬૪.૦૦૩૬૭.૭૦૩૫૦.૧૦૩૫૬.૪૦૩૮.૧૦L
2026-04-13૩૬૪.૮૦૩૭૦.૬૦૩૫૩.૧૫૩૫૮.૬૦૭૧.૧૨L
2026-04-10૩૨૧.૬૦૩૮૦.૨૦૩૧૮.૯૦૩૭૭.૯૦૪.૭૬Cr
2026-04-09૩૦૯.૪૫૩૨૫.૦૦૩૦૬.૦૦૩૧૬.૮૫૧૩.૮૮L
2026-04-08૩૧૧.૦૦૩૧૧.૯૫૩૦૦.૪૦૩૦૯.૫૦૮.૯૨L
2026-04-07૩૦૨.૯૦૩૦૬.૯૫૨૯૬.૭૫૩૦૦.૫૫૩.૦૦L
2026-04-02૩૦૯.૬૦૩૦૯.૬૫૩૦૦.૩૦૩૦૭.૨૫૨.૮૦L
2026-04-01૩૦૮.૯૫૩૧૭.૫૦૩૦૪.૦૦૩૧૧.૯૫૪.૯૮L
2026-03-27૩૦૫.૦૦૩૦૯.૦૦૨૯૬.૨૦૩૦૨.૭૦૧૦.૨૬L
2026-03-25૨૯૭.૫૦૩૧૨.૧૫૨૯૭.૪૦૩૦૬.૧૫૬.૪૫L
2026-03-24૩૦૭.૮૫૩૦૭.૮૫૨૯૩.૦૦૨૯૬.૩૦૫.૨૩L
2026-03-20૩૦૪.૨૫૩૦૪.૨૫૨૯૬.૦૫૨૯૯.૨૫૫.૧૫L
2026-03-19૩૦૧.૫૫૩૦૪.૨૦૨૯૫.૫૦૨૯૯.૨૫૩.૩૪L
2026-03-18૩૦૪.૩૦૩૦૯.૭૫૩૦૦.૪૫૩૦૬.૨૫૫.૨૨L

વારંવાર પૂછાતા પ્રશ્નો

વિશે

કોહાન્સ લાઇફસાયન્સ લિમિટેડ, જે અગાઉ સુવેન ફાર્માસ્યુટિકલ્સ તરીકે જાણીતી હતી, તે ભારત સ્થિત કોન્ટ્રાક્ટ ડેવલપમેન્ટ અને મેન્યુફેક્ચરિંગ સંસ્થા (CDMO) છે જે સંકલિત ફાર્માસ્યુટિકલ સેવાઓ પ્રદાન કરે છે. કંપની ફોર્મ્યુલેશન ડેવલપમેન્ટ, વિશ્લેષણાત્મક સેવાઓ અને વ્યાપારી ઉત્પાદન સહિત દવાના વિકાસ અને ઉત્પાદન માટે ટેક્નોલોજી આધારિત ઉકેલો પ્રદાન કરવામાં નિષ્ણાત છે.

Advertisement
BOARD OF DIRECTORS